Plasma leukocyte cell-derived chemotaxin 2 is associated with the severity of systemic inflammation in patients with sepsis

Microbiology and Immunology

Volumn 56, Issue 10, 2012, Pages 708-718

  Ando, Kazuyoshi ^a   Kato, Hidehito ^a   Kotani, Toru ^a   Ozaki, Makoto ^a   Arimura, Yutaka ^a   Yagi, Junji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

C reactive protein; Human inflammation; Leukocyte cell derived chemotaxin 2; Sepsis

Indexed keywords

C REACTIVE PROTEIN; CHEMOTAXIN; INTERLEUKIN 6; LEUKOCYTE CELL DERIVED CHEMOTAXIN 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL INDICATOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MALE; NEUTROPHIL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RETROSPECTIVE STUDY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PLASMA; SEPSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84866778924     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00488.x     Document Type: Article

References (32)

1. Yamagoe S., Yamakawa Y., Matsuo Y., Minowada J., Mizuno S., Suzuki K. (1996) Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol Lett 52: 9-13.
2. Yamagoe S., Mizuno S., Suzuki K. (1998) Molecular cloning of human and bovine LECT2 having a neutrophil chemotactic activity and its specific expression in the liver. Biochim Biophys Acta 1396: 105-13.
3. Saito T., Okumura A., Watanabe H., Asano M., Ishida-Okawara A., Sakagami J., Sudo K., Hatano-Yokoe Y., Bezbradica J.S., Joyce S., Abo T., Iwakura Y., Suzuki K., Yamagoe S. (2004) Increase in hepatic NKT cells in leukocyte cell-derived chemotaxin 2-deficient mice contributes to severe concanavalin A-induced hepatitis. J Immunol 173: 579-85.
4. Sato Y., Watanabe H., Kameyama H., Kobayashi T., Yamamoto S., Takeishi T., Hirano K., Oya H., Nakatsuka H., Watanabe T., Kokai H., Yamagoe S., Suzuki K., Oya K., Kojima K., Hatakeyama K. (2004) Changes in serum LECT 2 levels during the early period of liver regeneration after adult living related donor liver transplantation. Transplant Proc 36: 2357-58.
5. Ohtomi M., Nagai H., Ohtake H., Uchida T., Suzuki K. (2007) Dynamic change in expression of LECT2 during liver regeneration after partial hepatectomy in mice. Biomed Res 28: 247-53.
6. Okumura A., Saito T., Otani I., Kojima K., Yamada Y., Ishida-Okawara A., Nakazato K., Asano M., Kanayama K., Iwakura Y., Suzuki K., Yamagoe S. (2008) Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis. Arthritis Rheum 58: 413-21.
7. Dang M.H., Kato H., Ueshiba H., Omori-Miyake M., Yamagoe S., Ando K., Imanishi K., Arimura Y., Haruta I., Kotani T., Ozaki M., Suzuki K., Uchiyama T., Yagi J. (2010) Possible role of LECT2 as an intrinsic regulatory factor in SEA-induced toxicity in d-galactosamine-sensitized mice. Clin Immunol 137: 311-21.
8. Paterson R.L., Webster N.R. (2000) Sepsis and the systemic inflammatory response syndrome. J R Coll Surg Edinb 45: 178-82.
9. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-10.
10. Rivers E.P., Ahrens T. (2008) Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation. Crit Care Clin 24: S1-47.
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. (1992) Crit Care Med 20: 864-74.
12. Póvoa P., Almeida E., Moreira P., Fernandes A., Mealha R., Aragão A., Sabino H. (1998) C-reactive protein as an indicator of sepsis. Intensive Care Med 24: 1052-56.
13. Lobo S.M.A., Lobo F.R.M., Bota D.P., Lopes-Ferreira F., Soliman H.M., Mélot C., Vincent J.L. (2003) C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123: 2043-49.
14. van Deuren M., van der Ven-Jongekrijg J., Bartelink A.K.M., van Dalen R., Sauerwein R.W., van der Meer J.W.M. (1995) Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 172: 433-39.
15. Pinsky M.R. (2001) Sepsis: a pro- and anti-inflammatory disequilibrium syndrome. Contrib Nephrol 132: 354-66.
16. Wu H.P., Chen C.K., Chung K., Tseng J.C., Hua C.C., Liu Y.C., Chuang D.Y., Yang C.H. (2009) Serial cytokine levels in patients with severe sepsis. Inflamm Res 58: 385-93.
17. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 89: 4845-49.
18. Riordan F.A., Marzouk O., Thomson A.P., Sills J.A., Hart C.A. (1996) Proinflammatory and anti-inflammatory cytokines in meningococcal disease. Arch Dis Child 75: 453-54.
19. van der Poll T., van Deventer S.J. (1999) Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13: 413-26, ix.
20. Carrol E.D., Thomson A.P., Jones A.P., Jeffers G., Hart C.A. (2005) A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis. Intensive Care Med 31: 1415-19.
21. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M., E.G.-D.T.C. Group. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377.
22. Aikawa N., Fujishima S., Endo S., Sekine I., Kogawa K., Yamamoto Y., Kushimoto S., Yukioka H., Kato N., Totsuka K., Kikuchi K., Ikeda T., Ikeda K., Harada K., Satomura S. (2005) Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 11: 152-9.
23. Kinoshita S., Toyofuku M., Iida H., Wakiyama M., Kurihara M., Nakahara M., Nakata M., Nakashima K., Seo S., Hosaka N., Yano J., Misumoto T., Ishihara H., Ikeda K., Tsuchihashi M., Kawashima H., Imoto Y., Imamura K., Urabe Y., Shinohara K., Ooishi K., Abe T., Jinnouchi J., Hyoudou K., Kondo S., Kobayashi T., Ono J., Hamasaki N. (2001) Standardization of laboratory data and establishment of reference intervals in the Fukuoka Prefecture: a Japanese perspective. Clin Chem Lab Med 39: 256-262.
24. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-29.
25. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-10.
26. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515-8.
27. Meisner M., Tschaikowsky K., Palmaers T., Schmidt J. (1993) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3: 45-50.
28. Sato Y., Watanabe H., Kameyama H., Kobayashi T., Yamamoto S., Takeishi T., Hirano K., Oya H., Nakatsuka H., Watanabe T., Kokai H., Yamagoe S., Suzuki K., Oya K., Kojima K., Hatakeyama K. (2004) Serum LECT2 level as a prognostic indicator in acute liver failure. Transplant Proc 36: 2359-61.
29. Chen J., Lu X.J., Yang H.Y., Si Y.H. (2010) An interaction between a C-type lectin and leukocyte cell-derived chemotaxin 2 of ayu, Plecoglossus altivelis. Fish Shellfish Immunol 28: 245-48.
30. Chen J., Yang H.Y., Shi Y.H., Li M.Y. (2009) An interaction between leukocyte cell-derived chemotaxin 2 and transferrin of ayu, Plecoglossus altivelis. Fish Shellfish Immunol 26: 536-42.
31. Nishimoto N., Kishimoto T. (2006) Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2: 619-26.
32. Kameoka Y., Yamagoe S., Hatano Y., Kasama T., Suzuki K. (2000) Val58Ile polymorphism of the neutrophil chemoattractant LECT2 and rheumatoid arthritis in the Japanese population. Arthritis Rheum 43: 1419-20.